Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Debt forgiveness | $4,470 | 5 | 51.8% |
| Gift | $1,960 | 1 | 22.7% |
| Food and Beverage | $1,352 | 58 | 15.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $600.00 | 1 | 7.0% |
| Education | $250.35 | 3 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Olympus America Inc. | $4,560 | 8 | $0 (2024) |
| Allergan, Inc. | $1,960 | 1 | $0 (2020) |
| Abbott Laboratories | $600.00 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $328.56 | 7 | $0 (2023) |
| Smith & Nephew, Inc. | $208.91 | 2 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $196.22 | 9 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $183.57 | 12 | $0 (2024) |
| Antares Pharma, Inc. | $121.65 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $117.19 | 1 | $0 (2019) |
| Axonics, Inc. | $92.66 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,208 | 23 | Olympus America Inc. ($858.78) |
| 2023 | $4,166 | 23 | Olympus America Inc. ($3,612) |
| 2022 | $294.75 | 14 | Astellas Pharma US Inc ($116.72) |
| 2021 | $14.43 | 1 | Teleflex LLC ($14.43) |
| 2020 | $1,973 | 2 | Allergan, Inc. ($1,960) |
| 2019 | $117.19 | 1 | AstraZeneca Pharmaceuticals LP ($117.19) |
| 2018 | $765.13 | 3 | Abbott Laboratories ($600.00) |
| 2017 | $93.33 | 1 | Smith & Nephew, Inc. ($93.33) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: NEPHROLOGY | ||||||
| 11/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: UROLOGY | ||||||
| 11/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: UROLOGY | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $18.44 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: UROLOGY | ||||||
| 07/01/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Urology | ||||||
| 06/28/2024 | Olympus America Inc. | Olympus (Device) | Debt forgiveness | In-kind items and services | $3.29 | General |
| Category: Endotherapy | ||||||
| 06/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Oncology | ||||||
| 06/14/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Urology | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: Oncology | ||||||
| 05/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: UROLOGY | ||||||
| 05/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Oncology | ||||||
| 05/06/2024 | Olympus America Inc. | — | Debt forgiveness | In-kind items and services | $0.10 | General |
| 03/28/2024 | Olympus America Inc. | — | Debt forgiveness | In-kind items and services | $823.50 | General |
| 03/28/2024 | Olympus America Inc. | — | Debt forgiveness | In-kind items and services | $31.89 | General |
| 03/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Oncology | ||||||
| 03/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: UROLOGY | ||||||
| 02/09/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Urology | ||||||
| 02/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: UROLOGY | ||||||
| 12/13/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/13/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,584 | 2,727 | $737,858 | $153,077 |
| 2022 | 18 | 1,017 | 1,556 | $442,736 | $109,238 |
| 2021 | 16 | 1,147 | 1,881 | $470,332 | $118,320 |
| 2020 | 10 | 432 | 515 | $102,857 | $27,726 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 257 | 690 | $201,697 | $49,949 | 24.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 140 | 163 | $79,213 | $18,941 | 23.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 106 | $77,211 | $14,198 | 18.4% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 118 | 156 | $58,096 | $13,925 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 118 | $49,531 | $11,788 | 23.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 83 | 109 | $41,808 | $10,150 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $41,876 | $9,009 | 21.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 65 | 90 | $27,380 | $6,910 | 25.2% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2023 | 23 | 25 | $69,325 | $4,260 | 6.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $18,091 | $3,961 | 21.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 300 | 685 | $9,590 | $2,330 | 24.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 166 | 191 | $7,125 | $1,857 | 26.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 12 | 12 | $9,966 | $1,099 | 11.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 33 | $3,865 | $1,025 | 26.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 94 | 114 | $3,420 | $907.20 | 26.5% |
| 72194 | Ct scan of pelvis before and after contrast | Office | 2023 | 17 | 17 | $14,666 | $795.04 | 5.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 13 | 14 | $11,699 | $783.38 | 6.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 55 | $2,631 | $655.20 | 24.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 12 | 12 | $7,088 | $274.50 | 3.9% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 12 | 12 | $3,582 | $258.40 | 7.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 210 | 488 | $120,194 | $36,075 | 30.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 144 | 180 | $88,086 | $22,122 | 25.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 15 | 108 | $78,668 | $14,302 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 79 | $28,146 | $7,605 | 27.0% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 56 | 70 | $26,739 | $6,738 | 25.2% |
About Dr. John Hajjar, MD
Dr. John Hajjar, MD is a Urology healthcare provider based in Jersey City, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104894435.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Hajjar, MD has received a total of $8,632 in payments from pharmaceutical and medical device companies, with $1,208 received in 2024. These payments were reported across 68 transactions from 20 companies. The most common payment nature is "Debt forgiveness" ($4,470).
As a Medicare-enrolled provider, Hajjar has provided services to 4,180 Medicare beneficiaries, totaling 6,679 services with total Medicare billing of $408,361. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Jersey City, NJ
- Active Since 03/11/2006
- Last Updated 07/03/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104894435
Products in Payments
- EVIS EXERA lll COLONOVIDEOSCOPE (Device) $3,612
- ALLODERM (Device) $1,960
- Nubeqa (Drug) $196.22
- GEMTESA (Drug) $183.57
- FARXIGA (Drug) $117.19
- LENS Surgical Imaging System (Device) $115.58
- NOCDURNA (Drug) $107.54
- Journey II CR (Device) $93.33
- Axonics (Device) $92.66
- Myrbetriq (Drug) $78.21
- ERLEADA (Drug) $72.25
- EVIS EXERA (Device) $49.55
- iTIND System (Device) $40.43
- XYOSTED (Drug) $30.46
- Natesto (Drug) $25.77
- ELIGARD (Drug) $18.44
- TLANDO (Drug) $15.62
- JYNARQUE (Drug) $14.99
- UroLift System (Device) $14.43
- AVEED (Biological) $13.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Jersey City
Mr. Joel Abramowitz
Urology — Payments: $1,392
Elliot Shulman, Md, MD
Urology — Payments: $1,356
Yale Shulman, Md, MD
Urology — Payments: $1,290
Elliot Steigman, Md, MD
Urology — Payments: $361.87
Dr. John Hosay, M.d, M.D
Urology — Payments: $336.26
Asha Shah, M.d, M.D
Urology — Payments: $48.59